» Articles » PMID: 26873683

Midlife Cardiovascular Risk Factors and Late-Life Unrecognized and Recognized Myocardial Infarction Detect by Cardiac Magnetic Resonance: ICELAND-MI, the AGES-Reykjavik Study

Abstract

Background: Associations of atherosclerosis risk factors with unrecognized myocardial infarction (UMI) are unclear. We investigated associations of midlife risk factors with UMI and recognized MI (RMI) detected 31 years later by cardiac magnetic resonance.

Methods And Results: The Reykjavik Study (1967-1991) collected serial risk factors in subjects, mean (SD) age 48 (7) years. In ICELAND-MI (2004-2007), 936 survivors (76 (5) years) were evaluated by cardiac magnetic resonance. Analysis included logistic regression and random effects modeling. Comparisons are relative to subjects without MI. At baseline midlife evaluation, a modified Framingham risk score was significantly higher in RMI and in UMI versus no MI (7.4 (6.3)%; 7.1 (6.2)% versus 5.4 (5.8)%, P<0.001). RMI and UMI were more frequent in men (65%, 64% versus 43%; P<0.0001). Baseline systolic and diastolic blood pressure were significantly higher in UMI (138 (17) mm Hg versus 133 (17) mm Hg; P<0.006; 87 (10) mm Hg versus 84 (10) mm Hg; P<0.02). Diastolic BP was significantly higher in RMI (88 (10) mm Hg versus 84 (10) mm Hg; P<0.02). Cholesterol and triglycerides were significantly higher in RMI (6.7 (1.1) mmol/L versus 6.2 (1.1) mmol/L; P=0.0005; and 1.4 (0.7) mmol/L versus 1.1 (0.7) mmol/L; P<0.003). Cholesterol trended higher in UMI (P=0.08). Serial midlife systolic BP was significantly higher in UMI versus no MI (β [SE] = 2.69 [1.28] mm Hg, P=0.04). Serial systolic and diastolic BP were significantly higher in RMI versus no MI (4.12 [1.60] mm Hg, P=0.01 and 2.05 [0.91] mm Hg, P=0.03) as were cholesterol (0.43 [0.11] mmol/L, P=0.0001) and triglycerides (0.3 [0.06] mmol/L, P<0.0001).

Conclusions: Midlife vascular risk factors are associated with UMI and RMI detected by cardiac magnetic resonance 31 years later. Systolic blood pressure was the most significant modifiable risk factor associated with later UMI.

Citing Articles

Effect of Intensive Blood Pressure Lowering on the Risk of Incident Silent Myocardial Infarction: A Post Hoc Analysis of a Randomized Controlled Trial.

Kazibwe R, Ahmad M, Singh S, Chen L, Soliman E Ann Noninvasive Electrocardiol. 2024; 29(6):e70018.

PMID: 39359164 PMC: 11447273. DOI: 10.1111/anec.70018.


Associations of Midlife and Late-Life Blood Pressure Status With Late-Life Retinal OCT Measures.

Pan-Doh N, Guo X, Arsiwala-Scheppach L, Walker K, Sharrett A, Abraham A Transl Vis Sci Technol. 2023; 12(2):3.

PMID: 36729476 PMC: 9907367. DOI: 10.1167/tvst.12.2.3.


MIKB: A manually curated and comprehensive knowledge base for myocardial infarction.

Zhan C, Zhang Y, Liu X, Wu R, Zhang K, Shi W Comput Struct Biotechnol J. 2021; 19:6098-6107.

PMID: 34900127 PMC: 8626632. DOI: 10.1016/j.csbj.2021.11.011.


Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease.

Antiochos P, Ge Y, Steel K, Bingham S, Abdullah S, Mikolich J J Am Coll Cardiol. 2020; 76(8):945-957.

PMID: 32819469 PMC: 8691844. DOI: 10.1016/j.jacc.2020.06.063.


Sex-Based Differences in Unrecognized Myocardial Infarction.

van der Ende M, Juarez-Orozco L, Waardenburg I, Lipsic E, Schurer R, van der Werf H J Am Heart Assoc. 2020; 9(13):e015519.

PMID: 32573316 PMC: 7670510. DOI: 10.1161/JAHA.119.015519.


References
1.
James P, Oparil S, Carter B, Cushman W, Dennison-Himmelfarb C, Handler J . 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2013; 311(5):507-20. DOI: 10.1001/jama.2013.284427. View

2.
Mancia G, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34(28):2159-219. DOI: 10.1093/eurheartj/eht151. View

3.
Stone N, Robinson J, Lichtenstein A, Goff Jr D, Lloyd-Jones D, Smith Jr S . Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Ann Intern Med. 2014; 160(5):339-43. DOI: 10.7326/M14-0126. View

4.
Yano Y, Stamler J, Garside D, Daviglus M, Franklin S, Carnethon M . Isolated systolic hypertension in young and middle-aged adults and 31-year risk for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study. J Am Coll Cardiol. 2015; 65(4):327-335. PMC: 4948287. DOI: 10.1016/j.jacc.2014.10.060. View

5.
Wright Jr J, Williamson J, Whelton P, Snyder J, Sink K, Rocco M . A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015; 373(22):2103-16. PMC: 4689591. DOI: 10.1056/NEJMoa1511939. View